Cargando…
A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol
INTRODUCTION: During the last decade there has been a resurgence of interest on the use of psychedelics as novel treatments for mental disorders, including treatment-resistant depression (TRD). Psilocybin, the chemical component of “magic mushrooms”, has been administered with psychotherapy in rando...
Autores principales: | Husain, M. I., Blumberger, D. M., Castle, D. J., Kloiber, S. M., Ortiz, A., Rosenblat, J. D., Mulsant, B. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660879/ http://dx.doi.org/10.1192/j.eurpsy.2023.1175 |
Ejemplares similares
-
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023) -
Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023) -
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
por: Corrigan, Kate, et al.
Publicado: (2021) -
Rediscovering Psilocybin as an Antidepressive Treatment Strategy
por: Zeiss, Rene, et al.
Publicado: (2021) -
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)